cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Rhythm Pharmaceuticals Inc
8 own
11 watching
Current Price
$38.05
$-0.4
(-1.04%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
2,409.91M
52-Week High
52-Week High
52.57000
52-Week Low
52-Week Low
15.50000
Average Volume
Average Volume
0.11M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
82.6448
iconMarket Capitalization2,409.91M
icon52-Week High52.57000
icon52-Week Low15.50000
iconAverage Volume0.11M
iconDividend Yield--
iconP/E Ratio82.6448
What does the Rhythm Pharmaceuticals Inc do?
N/A
Read More
How much money does Rhythm Pharmaceuticals Inc make?
News & Events about Rhythm Pharmaceuticals Inc.
Globe Newswire
10 months ago
-- Mean BMI reduction of 21.0% from baseline observed in 13 patients at six months, showing progression from 16.8% mean BMI reduction at 16 weeks -- -- Phase 3 trial evaluating setmelanotide in acquired hypothalamic obesity ongoing; completion of enrollment expected 1Q 2024 -- BOSTON, June 17, 2023...
Globe Newswire
1 year ago
BOSTON, April 10, 2023 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on transforming the lives of patients and their families living with hyperphagia and severe obesity caused by rare melanocortin-4 receptor (MC4R) pathway ...
Globe Newswire
1 year ago
- Interview-based research published in Advances in Therapy demonstrates setmelanotide improved hyperphagia and reduced body weight and obsessive focus on food - Company also announces publication of health state utilities study in hyperphagia - BOSTON, March 27, 2023 (GLOBE NEWSWIRE) -- Rhythm ...
Globe Newswire
1 year ago
- Rare disease company in preclinical development for congenital hyperinsulinism - - Acquisition is strong strategic fit with Rhythms rare endocrinology focus and provides meaningful new development opportunity - - Expect to initiate clinical development in 2024 - BOSTON and AMSTERDAM, Feb. 27, 2023...
Frequently Asked Questions
Frequently Asked Questions
What is Rhythm Pharmaceuticals Inc share price today?
plus_minus_icon
Can Indians buy Rhythm Pharmaceuticals Inc shares?
plus_minus_icon
How can I buy Rhythm Pharmaceuticals Inc shares from India?
plus_minus_icon
Can Fractional shares of Rhythm Pharmaceuticals Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Rhythm Pharmaceuticals Inc stocks?
plus_minus_icon
What is today’s traded volume of Rhythm Pharmaceuticals Inc?
plus_minus_icon
What is today’s market capitalisation of Rhythm Pharmaceuticals Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Rhythm Pharmaceuticals Inc?
plus_minus_icon
What percentage is Rhythm Pharmaceuticals Inc down from its 52-Week High?
plus_minus_icon
What percentage is Rhythm Pharmaceuticals Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$38.05
$-0.4
(-1.04%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00